Broker recommendations for Merck & Co.
The Merck & Co., Inc. stock is rated at 1.285714 (on a scale 1-3, where 1 is ‘strong buy‘ and 3 is ‘strong sell‘) from Wednesday 21 October, 2020 by a total of 21 brokers. This means that the consensus of the 21 different brokers is leaning toward to buy/moderate buy.
Sell
0 (0%) Underweight
0 (0%) Hold
5 (23.81%) Overweight
2 (9.52%) Buy
14 (66.67%)
Price target by analysts
The 18 latest analyst estimates, per Wednesday 21 October, 2020, show the following high, low and average price targets.
Target Average: 95.83 USD
Target High: 107 USD
Target Low: 84 USD
Merck & Co., Inc. (NYSE:MRK) Coverage Initiated at Truist
Saturday, 24 October 2020, 15:04:42
Truist assumed coverage on shares of Merck & Co., Inc. (NYSE:MRK) in a research report sent to investors on Friday, The Fly reports. The firm issued a buy rating and a $96.00 price target on the stock. Other analysts have also recently issued reports about the company. Goldman Sachs Group raised Merck & Co., Inc. […]
— Transcript Daily
Merck & Co., Inc. (NYSE:MRK) Coverage Initiated by Analysts at Truist
Saturday, 24 October 2020, 11:04:42
Truist started coverage on shares of Merck & Co., Inc. (NYSE:MRK) in a research report sent to investors on Friday morning, The Fly reports. The firm issued a buy rating and a $96.00 target price on the stock. Several other research firms have also recently commented on MRK. Royal Bank of Canada reiterated a hold […]
— Stock Observer
miRNA Kits Market to Witness Huge Growth by 2026 | Thermo Fisher Scientific, Agilent, Sigma-Aldrich(Merck)
Friday, 23 October 2020, 22:26:02
Global miRNA Kits Market Report 2020 is latest research study released by HTF MI evaluating the market, highlighting opportunities, risk side analysis, and leveraged with strategic and tactical decision-making support. The study provides information on market trends and development, drivers,
— OpenPR
Global Women’s Health Market Analysis 2020 With COVID 19 Impact Analysis| Leading Players In-depth Analysis Research Report Foresight to 2027 || Pfizer Inc., Merck & Co., Inc., Novo Nordisk A/S, Amgen Inc., Lupin Pharmaceuticals, Inc., AstraZeneca
Friday, 23 October 2020, 20:22:00
The Global Women’s Health Market report offers meticulous investigation of current scenario of the global market, which considers numerous market dynamics. This market report identifies and analyses the emerging trends along with key drivers, challenges and opportunities in the ABC
— OpenPR
Why Merck Is Playing Catch-Up in the Coronavirus Vaccine Chase
Friday, 23 October 2020, 18:33:00
Initial hesitation by senior executives about joining the global effort puts the company in an unusual spot: behind.
— The Wall Street Journal
We recommend that you check out Capital.com as they have a very good selection of stocks available for both going short and long.
